To further investigate the mechanisms associated with LINE-1 expression control, we also evaluated if ORF1p de-repression was correlated to ARID1A mutations, a common genetic alteration in clear cell ovarian carcinomas, and to TP53 mutations, a known LINE-1 regulator43,44. The gene discussed is ARID1A; the disease is ovarian clear cell cancer.